Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06453083 · ClinicalTrials.gov registry record · Early Phase 1
Medrol Dose Packs for Post-Operative Pain Control
A Early Phase 1 study of Pain, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT06453083 is a Early Phase 1 study of Pain that has completed, run by University of Utah. The registered enrollment target is 57 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06453083, a Early Phase 1 study of Pain, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Medrol
Study Locations (1)
Utah
- University of Utah Orthopaedic Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2023-01-13 |
| Est. Completion | 2024-12-17 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06453083
The ClinicalTrials.gov registry entry for NCT06453083 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (81% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06453083 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT06453083 about?
NCT06453083 is a clinical study titled "Medrol Dose Packs for Post-Operative Pain Control". The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.
What is the current status of trial NCT06453083?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 57 participants. The study started on 2023-01-13. Estimated completion is 2024-12-17.
What conditions does trial NCT06453083 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT06453083?
The interventions under investigation include: Placebo (DRUG), Medrol (DRUG).
Who is sponsoring clinical trial NCT06453083?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06453083 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
RECRUITING · Early Phase 1
-
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
RECRUITING · Early Phase 1
-
Effects of Dronabinol in Opioid Maintained Patients
RECRUITING · Early Phase 1
-
Remimazolam NeuroImaging
RECRUITING · Early Phase 1
-
Nitrous Oxide Neuroimaging
RECRUITING · Early Phase 1
-
Ketamine and Propofol NeuroImaging
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.